Recombinant Porcine circovirus 2 Porcine circovirus 2 Capsid Protein，His & SUMO

Porcine circovirus type 2 (PCV2) is a small, non-enveloped virus that belongs to the Circoviridae family and is primarily associated with various porcine diseases, including post-weaning multisystemic wasting syndrome (PMWS). The PCV2 capsid protein plays a crucial role in viral assembly, immunogenicity, and serotype determination, making it a key target for vaccine development and therapeutic interventions. Research into recombinant PCV2 capsid proteins has gained momentum due to the urgent need for effective vaccines to combat the economic losses caused by PCV2 infections in the swine industry. The use of recombinant DNA technology allows for the expression of the capsid protein in various host systems, facilitating the production of vaccines that can elicit protective immune responses in pigs. Moreover, studies have shown that the capsid protein can serve as an effective antigen for serological assays, enabling the monitoring of PCV2 circulation in livestock populations. Understanding the structure and function of the PCV2 capsid protein is essential for developing targeted strategies to control the virus and improve animal health. Consequently, ongoing research focuses on optimizing production methods, characterizing immune responses, and evaluating the efficacy of capsid-based vaccines in field trials. This research is critical not only for enhancing biosecurity in pig farming but also for reducing the reliance on antibiotics, addressing broader concerns related to animal welfare and public health.